Research Impact

h-index

N/A

Research impact score

Publications

Total publications

Trial Results

Published trial results

Citations

Total citations

Drug Portfolio

MIXED(4)

DRUG(1)

4 unique interventions2 categories

Analytics

Trial Phases

Phase 32

Phase 41

Trial Status

Completed3

Terminated1

Role Distribution

Other Roles4

Activity Timeline

Clinical Trials (4)

NCT01938404Terminated

Octaplas Adult TTP Trial

Thrombotic Thrombocytopenic Purpura

StudydirectorStart date: 2017-06-06

NCT02728752Phase 3Completed

Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)

Dermatomyositis

StudydirectorStart date: 2017-02-27

NCT01888484Phase 3Completed

Study of Octanorm Subcutaneous IG in Patients With PID

Primary Immune Deficiency Disorder

Studydirector

NCT02050841Phase 4Completed

Octaplas Pediatric Plasma Replacement Trial

Cardiac SurgeryCoagulopathyLiver Dysfunction+1 more

Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Surgery, Cardiac1 Coagulopathy1 Dermatomyositis1 Liver Dysfunction1 Liver Surgery1 Primary Immunodeficiency Diseases1 Purpura, Thrombotic Thrombocytopenic1

Affiliations

International Medical Director

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Thomas Ortel, MD

Duke University

4 trials

Shared therapeutic areas:

Surgery, CardiacPurpura, Thrombotic Thrombocytopenic

Similarity Score9%

James George, MD

University of Oklahoma

3 trials

Shared therapeutic areas:

Surgery, CardiacPurpura, Thrombotic Thrombocytopenic

Similarity Score9%

Paul Ness, MD

Johns Hopkins University

4 trials

Shared therapeutic areas:

Surgery, CardiacPurpura, Thrombotic Thrombocytopenic

Similarity Score9%

Karin BILGER, MD

Hôpital de Haute-Pierre, Strasbourg

1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic

Similarity Score4%

Marie-Christine THOURET, MD

CHU de l'Archet 2, Nice

1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic

Similarity Score4%

Hubert NIVET, MD, PhD

Hôpital Gatien de Clovheville, Tours

1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic

Similarity Score4%

Jacques POURRAT, MD, PhD

Hôpital de Rangueil, Toulouse

1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic

Similarity Score4%

Dong-Xin Wang, MD, PhD

Peking University First Hospital

74 trials

Shared therapeutic areas:

Surgery, Cardiac

Similarity Score4%

Sylvain LAVOUÉ, PH

CHU Pontchaillou, Service de maladies infectieuses et réanimation médicale, RENNES

1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic

Similarity Score4%

Philippe VANHILLE, MD

CH de Valenciennes, Valenciennes

1 trials

Shared therapeutic areas:

Purpura, Thrombotic Thrombocytopenic

Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT01938404StudyDirector

Octaplas Adult TTP Trial

Thrombotic Thrombocytopenic Purpura

Terminated

NCT02728752Phase 3StudyDirector

Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)

Dermatomyositis

Completed

NCT01888484Phase 3StudyDirector

Study of Octanorm Subcutaneous IG in Patients With PID

Primary Immune Deficiency Disorder

Completed

NCT02050841Phase 4StudyDirector

Octaplas Pediatric Plasma Replacement Trial

Cardiac SurgeryCoagulopathyLiver Dysfunction+1 more

Completed

All 4 trials loaded